Clinical Trial

China Extracorporeal Life Support Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Extracorporeal life support (ECLS), also known as extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective cardiac and respiratory support to patients with lungs and/or heart failure. There was a growth in ECLS cases, centers, and center scale in China during the past decade. This multi-center registry was conducted by Chinese Society of Extracorporeal Life Support. The objectives were to investigate China statistics of ECLS and to evaluate the short-term and long-term outcomes of patients with ECLS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-11-07.
Trial Details
NCT Number NCT04158479
Lead Sponsor Beijing Anzhen Hospital
Conditions Cardiogenic Shock, Cardiac Arrest, Heart Failure, Acute Respiratory Distress Syndrome, Acute Respiratory Failure
Enrollment 20,000 participants
Start Date 2017-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-04-09